Drug fails to reduce prostatitis symptoms.
Although commonly prescribed to treat chronic prostatitis/chronic pelvic pain syndrome, alfuzosin (Uroxatral), a member of a class of drugs known as alpha blockers, did not significantly reduce symptoms in recently diagnosed men who had not previously used an alpha blocker, according to a study published Dec. 18 in the New England Journal of Medicine. Chronic prostatitis causes pain and urinary and sexual problems. In the study, 272 men diagnosed with the disorder received either alfuzosin or a placebo for 12 weeks. The researchers found no significant differences in measures of pain, urination problems and effects on quality of life in the two study groups.
|Printer friendly Cite/link Email Feedback|
|Publication:||Men's Health Advisor|
|Date:||Mar 1, 2009|
|Previous Article:||Just 'senior moments' or signs of something more serious? Subtle memory declines are natural with aging, but cognitive problems that affect your life...|
|Next Article:||Get more sleep to improve your immunity and heart health.|